Clinical Prospect of Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles in Kidney Disease: Challenges and the Way Forward

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2023 Jul 29

PMID 37514097

Authors

Maja Kosanovic

Bojana Milutinovic

Tanja J Kutzner

Yanis Mouloud

Milica Bozic

Affiliations

Soon will be listed here.

Abstract

Kidney disease is a growing public health problem worldwide, including both acute and chronic forms. Existing therapies for kidney disease target various pathogenic mechanisms; however, these therapies only slow down the progression of the disease rather than offering a cure. One of the potential and emerging approaches for the treatment of kidney disease is mesenchymal stromal/stem cell (MSC) therapy, shown to have beneficial effects in preclinical studies. In addition, extracellular vesicles (EVs) released by MSCs became a potent cell-free therapy option in various preclinical models of kidney disease due to their regenerative, anti-inflammatory, and immunomodulatory properties. However, there are scarce clinical data available regarding the use of MSC-EVs in kidney pathologies. This review article provides an outline of the renoprotective effects of MSC-EVs in different preclinical models of kidney disease. It offers a comprehensive analysis of possible mechanisms of action of MSC-EVs with an emphasis on kidney disease. Finally, on the journey toward the implementation of MSC-EVs into clinical practice, we highlight the need to establish standardized methods for the characterization of an EV-based product and investigate the adequate dosing, safety, and efficacy of MSC-EVs application, as well as the development of suitable potency assays.

Citing Articles

Extracellular Vesicles in Viral Liver Diseases.

Kouroumalis E, Tsomidis I, Voumvouraki A Viruses. 2024; 16(11).

PMID: 39599900 PMC: 11598962. DOI: 10.3390/v16111785.

Unraveling the Multifaceted Roles of Extracellular Vesicles: Insights into Biology, Pharmacology, and Pharmaceutical Applications for Drug Delivery.

Al-Jipouri A, Eritja A, Bozic M Int J Mol Sci. 2024; 25(1).

PMID: 38203656 PMC: 10779093. DOI: 10.3390/ijms25010485.

A Supportive Role of Mesenchymal Stem Cells on Insulin-Producing Langerhans Islets with a Specific Emphasis on The Secretome.

Sionov R, Ahdut-HaCohen R Biomedicines. 2023; 11(9).

PMID: 37761001 PMC: 10527322. DOI: 10.3390/biomedicines11092558.

References

Feng Y, Huang W, Wani M, Yu X, Ashraf M . Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One. 2014; 9(2):e88685. PMC: 3928277. DOI: 10.1371/journal.pone.0088685. View

Papait A, Silini A, Gazouli M, Malvicini R, Muraca M, ODriscoll L . Perinatal derivatives: How to best validate their immunomodulatory functions. Front Bioeng Biotechnol. 2022; 10:981061. PMC: 9518643. DOI: 10.3389/fbioe.2022.981061. View

Crain S, Robinson S, Thane K, Davis A, Meola D, Barton B . Extracellular Vesicles from Wharton's Jelly Mesenchymal Stem Cells Suppress CD4 Expressing T Cells Through Transforming Growth Factor Beta and Adenosine Signaling in a Canine Model. Stem Cells Dev. 2018; 28(3):212-226. DOI: 10.1089/scd.2018.0097. View

Guo R, Liang Q, He Y, Wang C, Jiang J, Chen T . Mesenchymal Stromal Cells-Derived Extracellular Vesicles Regulate Dendritic Cell Functions in Dry Eye Disease. Cells. 2023; 12(1). PMC: 9818747. DOI: 10.3390/cells12010033. View

van der Pol E, Boing A, Gool E, Nieuwland R . Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles. J Thromb Haemost. 2015; 14(1):48-56. DOI: 10.1111/jth.13190. View

Ridder K, Keller S, Dams M, Rupp A, Schlaudraff J, Del Turco D . Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol. 2014; 12(6):e1001874. PMC: 4043485. DOI: 10.1371/journal.pbio.1001874. View

Lee M, Lee F, Chen Y, Sung P, Chiang H, Chen K . Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial. Oncotarget. 2017; 8(11):17750-17762. PMC: 5392283. DOI: 10.18632/oncotarget.14831. View

Phinney D, Kopen G, Righter W, Webster S, Tremain N, Prockop D . Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem. 1999; 75(3):424-36. View

Liu J, Kuwabara A, Kamio Y, Hu S, Park J, Hashimoto T . Human Mesenchymal Stem Cell-Derived Microvesicles Prevent the Rupture of Intracranial Aneurysm in Part by Suppression of Mast Cell Activation via a PGE2-Dependent Mechanism. Stem Cells. 2016; 34(12):2943-2955. PMC: 5287411. DOI: 10.1002/stem.2448. View

10.

Bozic M, Valdivielso J . Calcium signaling in renal tubular cells. Adv Exp Med Biol. 2012; 740:933-44. DOI: 10.1007/978-94-007-2888-2_42. View

11.

Wang Y, Lu X, He J, Zhao W . Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease. Stem Cell Res Ther. 2015; 6:100. PMC: 4469245. DOI: 10.1186/s13287-015-0095-0. View

12.

Grange C, Tritta S, Tapparo M, Cedrino M, Tetta C, Camussi G . Stem cell-derived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy. Sci Rep. 2019; 9(1):4468. PMC: 6418239. DOI: 10.1038/s41598-019-41100-9. View

13.

Gao F, Zuo B, Wang Y, Li S, Yang J, Sun D . Protective function of exosomes from adipose tissue-derived mesenchymal stem cells in acute kidney injury through SIRT1 pathway. Life Sci. 2020; 255:117719. DOI: 10.1016/j.lfs.2020.117719. View

14.

Lu F, Chen D, Chen L, Hu E, Wu J, Li H . Attenuation of Experimental Autoimmune Hepatitis in Mice with Bone Mesenchymal Stem Cell-Derived Exosomes Carrying MicroRNA-223-3p. Mol Cells. 2019; 42(12):906-918. PMC: 6939658. DOI: 10.14348/molcells.2019.2283. View

15.

Sun J, Sun X, Chen J, Liao X, He Y, Wang J . microRNA-27b shuttled by mesenchymal stem cell-derived exosomes prevents sepsis by targeting JMJD3 and downregulating NF-κB signaling pathway. Stem Cell Res Ther. 2021; 12(1):14. PMC: 7791667. DOI: 10.1186/s13287-020-02068-w. View

16.

Fan Y, Herr F, Vernochet A, Mennesson B, Oberlin E, Durrbach A . Human Fetal Liver Mesenchymal Stem Cell-Derived Exosomes Impair Natural Killer Cell Function. Stem Cells Dev. 2018; 28(1):44-55. DOI: 10.1089/scd.2018.0015. View

17.

Lechanteur C, Briquet A, Bettonville V, Baudoux E, Beguin Y . MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process. Cells. 2021; 10(6). PMC: 8227789. DOI: 10.3390/cells10061320. View

18.

Witwer K, van Balkom B, Bruno S, Choo A, Dominici M, Gimona M . Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles. 2019; 8(1):1609206. PMC: 6493293. DOI: 10.1080/20013078.2019.1609206. View

19.

Barbado J, Tabera S, Sanchez A, Garcia-Sancho J . Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis. Lupus. 2018; 27(13):2161-2165. DOI: 10.1177/0961203318804922. View

20.

Deng H, Wu L, Liu M, Zhu L, Chen Y, Zhou H . Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Attenuate LPS-Induced ARDS by Modulating Macrophage Polarization Through Inhibiting Glycolysis in Macrophages. Shock. 2020; 54(6):828-843. DOI: 10.1097/SHK.0000000000001549. View